Annalisa Bonifacio

Vepafestinib is a pharmacologically advanced RET-selective inhibitor with high CNS penetration and inhibitory activity against RET solvent front mutations

M. Ladanyi, R. Somwar, E. de Stanchina, 2023, Nature Cancer.